Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05466604
Other study ID # YDU/2019//74-921
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date December 1, 2019
Est. completion date June 30, 2022

Study information

Verified date July 2022
Source Hacettepe University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The present study is designed to reveal effectiveness of hyaluronidase and dexamethasone on reduction of postoperative edema, pain, trismus, and infection. For this purpose, 60 participants with symmetrical mandibular wisdom teeth enrolled the present study. All measurements and evaluations were performed before and 1, 2, 3, and 7 days later the operation.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date June 30, 2022
Est. primary completion date June 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - symmetrical mandibular wisdom teeth with bone retention - patients who are signed informed consent and acceptance of study involvement forms Exclusion Criteria: - existence of any systemic disease - existence of any periodical drug intake - existence of difference in operation times of right and left impacted wisdom teeth extractions more than 5 minutes - existence of pregnancy - existence of breastfeeding

Study Design


Intervention

Drug:
Hyaluronidase Injection mesomedica
injection of 150 IU hyaluronidase to perioperative region, submucosally.
Dexamethasone dekort
injection of 8 mg dexamethasone to perioperative region, submucosally.

Locations

Country Name City State
Cyprus Near East University Nicosia
Turkey Hacettepe University Ankara Sihhiye

Sponsors (1)

Lead Sponsor Collaborator
Hacettepe University

Countries where clinical trial is conducted

Cyprus,  Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary evaluation of the increase of edema in postoperative 1. day using a measuring tape in hyaluronidase experimental group preoperative edema amount was subtracted from edema amount in 1. day in hyaluronidase experimental group postoperative 1. day
Primary evaluation of the increase of edema in postoperative 2. day using a measuring tape in hyaluronidase experimental group preoperative edema amount was subtracted from edema amount in 2. day in hyaluronidase experimental group postoperative 2. day
Primary evaluation of the increase of edema in postoperative 3. day using a measuring tape in hyaluronidase experimental group preoperative edema amount was subtracted from edema amount in 3. day in hyaluronidase experimental group postoperative 3. day
Primary evaluation of the increase of edema in postoperative 7. day using a measuring tape in hyaluronidase experimental group preoperative edema amount was subtracted from edema amount in 7. day in hyaluronidase experimental group postoperative 7. day
Primary evaluation of the increase of edema in postoperative 1. day using a measuring tape in hyaluronidase control group preoperative edema amount was subtracted from edema amount in 1. day in hyaluronidase control group postoperative 1. day
Primary evaluation of the increase of edema in postoperative 2. day using a measuring tape in hyaluronidase control group preoperative edema amount was subtracted from edema amount in 2. day in hyaluronidase control group postoperative 2. day
Primary evaluation of the increase of edema in postoperative 3. day using a measuring tape in hyaluronidase control group preoperative edema amount was subtracted from edema amount in 3. day in hyaluronidase control group postoperative 3. day
Primary evaluation of the increase of edema in postoperative 7. day using a measuring tape in hyaluronidase control group preoperative edema amount was subtracted from edema amount in 7. day in hyaluronidase control group postoperative 7. day
Primary evaluation of the increase of edema in postoperative 1. day using a measuring tape in dexamethasone experimental group preoperative edema amount was subtracted from edema amount in 1. day in dexamethasone experimental group postoperative 1. day
Primary evaluation of the increase of edema in postoperative 2. day using a measuring tape in dexamethasone experimental group preoperative edema amount was subtracted from edema amount in 2. day in dexamethasone experimental group postoperative 2. day
Primary evaluation of the increase of edema in postoperative 3. day using a measuring tape in dexamethasone experimental group preoperative edema amount was subtracted from edema amount in 3. day in dexamethasone experimental group postoperative 3. day
Primary evaluation of the increase of edema in postoperative 7. day using a measuring tape in dexamethasone experimental group preoperative edema amount was subtracted from edema amount in 7. day in dexamethasone experimental group postoperative 7. day
Primary evaluation of the increase of edema in postoperative 1. day using a measuring tape in dexamethasone control group preoperative edema amount was subtracted from edema amount in 1. day in dexamethasone controlgroup postoperative 1. day
Primary evaluation of the increase of edema in postoperative 2. day using a measuring tape in dexamethasone control group preoperative edema amount was subtracted from edema amount in 2. day in dexamethasone controlgroup postoperative 2. day
Primary evaluation of the increase of edema in postoperative 3. day using a measuring tape in dexamethasone control group preoperative edema amount was subtracted from edema amount in 3. day in dexamethasone controlgroup postoperative 3. day
Primary evaluation of the increase of edema in postoperative 7. day using a measuring tape in dexamethasone control group preoperative edema amount was subtracted from edema amount in 7. day in dexamethasone controlgroup postoperative 7. day
Primary evaluation of the difference in increase amounts of edema between hyaluronidase experimental and hyaluronidase control groups in postoperative 1. day using a measuring tape edema increase amount of hyaluronidase experimental group was compared with that of hyaluronidase control group in postoperative 1. day postoperative 1. day
Primary evaluation of the difference in increase amounts of edema between hyaluronidase experimental and hyaluronidase control groups in postoperative 2. day using a measuring tape edema increase amount of hyaluronidase experimental group was compared with that of hyaluronidase control group in postoperative 2. day postoperative 2. day
Primary evaluation of the difference in increase amounts of edema between hyaluronidase experimental and hyaluronidase control groups in postoperative 3. day using a measuring tape edema increase amount of hyaluronidase experimental group was compared with that of hyaluronidase control group in postoperative 3. day postoperative 3. day
Primary evaluation of the difference in increase amounts of edema between hyaluronidase experimental and hyaluronidase control groups in postoperative 7. day using a measuring tape edema increase amount of hyaluronidase experimental group was compared with that of hyaluronidase control group in postoperative 7. day postoperative 7. day
Primary evaluation of the difference in increase amounts of edema between dexamethasone experimental and dexamethasone control groups in postoperative 1. day using a measuring tape edema increase amount of dexamethasone experimental group was compared with that of dexamethasone control group in postoperative 1. day postoperative 1. day
Primary evaluation of the difference in increase amounts of edema between dexamethasone experimental and dexamethasone control groups in postoperative 2. day using a measuring tape edema increase amount of dexamethasone experimental group was compared with that of dexamethasone control group in postoperative 2. day postoperative 2. day
Primary evaluation of the difference in increase amounts of edema between dexamethasone experimental and dexamethasone control groups in postoperative 3. day using a measuring tape edema increase amount of dexamethasone experimental group was compared with that of dexamethasone control group in postoperative 3. day postoperative 3. day
Primary evaluation of the difference in increase amounts of edema between dexamethasone experimental and dexamethasone control groups in postoperative 7. day using a measuring tape edema increase amount of dexamethasone experimental group was compared with that of dexamethasone control group in postoperative 7. day postoperative 7. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in hyaluronidase experimental group in postoperative 1. day pain intensity of the patients in hyaluronidase experimental group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 1. day postoperative 1. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in hyaluronidase experimental group in postoperative 2. day pain intensity of the patients in hyaluronidase experimental group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 2. day postoperative 2. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in hyaluronidase experimental group in postoperative 3. day pain intensity of the patients in hyaluronidase experimental group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 3. day postoperative 3. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in hyaluronidase experimental group in postoperative 4. day pain intensity of the patients in hyaluronidase experimental group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 4. day postoperative 4. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in hyaluronidase experimental group in postoperative 5. day pain intensity of the patients in hyaluronidase experimental group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 5. day postoperative 5. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in hyaluronidase experimental group in postoperative 6. day pain intensity of the patients in hyaluronidase experimental group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 6. day postoperative 6. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in hyaluronidase experimental group in postoperative 7. day pain intensity of the patients in hyaluronidase experimental group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 7. day postoperative 7. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in hyaluronidase control group in postoperative 1. day pain intensity of the patients in hyaluronidase control group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 1. day postoperative 1. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in hyaluronidase control group in postoperative 2. day pain intensity of the patients in hyaluronidase control group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 2. day postoperative 2. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in hyaluronidase control group in postoperative 3. day pain intensity of the patients in hyaluronidase control group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 3. day postoperative 3. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in hyaluronidase control group in postoperative 4. day pain intensity of the patients in hyaluronidase control group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 4. day postoperative 4. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in hyaluronidase control group in postoperative 5. day pain intensity of the patients in hyaluronidase control group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 5. day postoperative 5. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in hyaluronidase control group in postoperative 6. day pain intensity of the patients in hyaluronidase control group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 6. day postoperative 6. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in hyaluronidase control group in postoperative 7. day pain intensity of the patients in hyaluronidase control group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 7. day postoperative 7. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in dexamethasone experimental group in postoperative 1. day pain intensity of the patients in dexamethasone experimental group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 1. day postoperative 1. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in dexamethasone experimental group in postoperative 2. day pain intensity of the patients in dexamethasone experimental group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 2. day postoperative 2. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in dexamethasone experimental group in postoperative 3. day pain intensity of the patients in dexamethasone experimental group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 3. day postoperative 3. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in dexamethasone experimental group in postoperative 4. day pain intensity of the patients in dexamethasone experimental group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 4. day postoperative 4. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in dexamethasone experimental group in postoperative 5. day pain intensity of the patients in dexamethasone experimental group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 5. day postoperative 5. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in dexamethasone experimental group in postoperative 6. day pain intensity of the patients in dexamethasone experimental group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 6. day postoperative 6. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in dexamethasone experimental group in postoperative 7. day pain intensity of the patients in dexamethasone experimental group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 7. day postoperative 7. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in dexamethasone control group in postoperative 1. day pain intensity of the patients in dexamethasone control group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 1. day postoperative 1. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in dexamethasone control group in postoperative 2. day pain intensity of the patients in dexamethasone control group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 2. day postoperative 2. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in dexamethasone control group in postoperative 3. day pain intensity of the patients in dexamethasone control group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 3. day postoperative 3. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in dexamethasone control group in postoperative 4. day pain intensity of the patients in dexamethasone control group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 4. day postoperative 4. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in dexamethasone control group in postoperative 5. day pain intensity of the patients in dexamethasone control group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 5. day postoperative 5. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in dexamethasone control group in postoperative 6. day pain intensity of the patients in dexamethasone control group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 6. day postoperative 6. day
Primary evaluation of the pain using visual analog scale (VAS) and daily count of NSAI drug intake in dexamethasone control group in postoperative 7. day pain intensity of the patients in dexamethasone control group was assessed using visual analog scale (VAS) and daily count of NSAI drug intake in postoperative 7. day postoperative 7. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase experimental group preoperatively. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler preoperative
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase experimental group in postoperative 1. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 1. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase experimental group in postoperative 2. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 2. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase experimental group in postoperative 3. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 3. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase experimental group in postoperative 7. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 7. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase control group preoperatively. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler preoperative
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase control group in postoperative 1. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 1. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase control group in postoperative 2. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 2. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase control group in postoperative 3. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 3. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of hyaluronidase control group in postoperative 7. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 7. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone experimental group preoperatively. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler preoperative
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone experimental group in postoperative 1. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 1. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone experimental group in postoperative 2. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 2. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone experimental group in postoperative 3. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 3. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone experimental group in postoperative 7. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 7. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone control group preoperatively. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler preoperative
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone control group in postoperative 1. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 1. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone control group in postoperative 2. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 2. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone control group in postoperative 3. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 3. day
Primary evaluation of trismus using a ruler, which measures the opening between mandibular and maxillary right first incisors of dexamethasone control group in postoperative 7. day. amount of trismus is revealed measuring the distance between the tips of incisal edges of mandibular and maxillary right first incisors using a ruler postoperative 7. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase experimental group preoperatively. existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. preoperative
Primary evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase experimental group in postoperative 1. day. existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 1. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase experimental group in postoperative 2. day. existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 2. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase experimental group in postoperative 3. day. existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 3. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase experimental group in postoperative 7. day. existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 7. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase control group preoperatively. existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. preoperative
Primary evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase control group in postoperative 1. day. existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 1. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase control group in postoperative 2. day. existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 2. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase control group in postoperative 3. day. existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 3. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of hyaluronidase control group in postoperative 7. day. existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 7. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone experimental group preoperatively. existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. preoperative
Primary evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone experimental group in postoperative 1. day existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 1. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone experimental group in postoperative 2. day existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 2. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone experimental group in postoperative 3. day existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 3. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone experimental group in postoperative 7. day existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 7. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone control group preoperatively. existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. preoperatively
Primary evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone control group in postoperative 1. day existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 1. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone control group in postoperative 2. day existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 2. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone control group in postoperative 3. day existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 3. day
Primary evaluation of infection in operation site via determination of infection signs in physical examination of dexamethasone control group in postoperative 7. day existence of infection signs were determined using physical examination method. if the count of + signs are more than half of total amount of determined signs, the evaluation is accepted as (+) infected. postoperative 7. day
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care